Journal of Nutrition and Health

The Korean Nutrition Society (한국영양학회)
권호 표지

The Effect of Endogenous and Exogenous Estrogen on Risk Factors of Coronary Heart Disease -Part II : On Platelet Aggregation-

내인성 및 외인성 Estogen이 관상동맥질환 위험인자에 미치는 영향 -제2보: 내인성 및 외인성 Estrogen이 혈소판 응집에 미치는 영향-

  • 박유신 (한양대학교 생활과학대학 식품영양학과)
  • Published : 1999.07.01
Download PDF
⟨ Previous Next ⟩

Abstract

In the atherosclerotic subjects, arterial endothelial cell injury and plaque formation are suspected to be strong causable factors in developing acute coronary syndrome, and it was revealed that platelets have a very important role in this case. Women are exposed to atherosclerosis at a different degree after menopause or oral contraception. The purpose of this study was to determine the effects of endogenous and exogenous estrogen on the degree of platelet aggregation in platelet rich plasma(PRP) in twenty nonsmoking healthy Korean women for 12 weeks. The subjects were assigned to three groups: (1) eight women aged 49 to 60(yr) for the postmenopausel(Pst) group, (2) eight, aged 22 to 30(yr) for the premenopausa(Pre) group, (3) four, aged 23 to 30(yr) for the oral contraceptive (OC) group which used triphasic OC formulation. Fasting blood sample were obtained from the subjects, (1) once per 6 weeks in the Pst group, (2) every phase of the menstrual cycle in the Pre group, (3) each once during and after OC administration in the OC group. ADP, collagen and epinephrine were used as aggregating reagents, and platelet aggregation and time(Δt: time reaching to the maximum point of aggregation) in PRP were measured at the maximum point of aggregation in five minutes. All the data were adjusted for dietary effects, personality type and body mass index(BMI) by using analysis of covariation(ANCOVA). Platelet aggregation to ADP and collagen(MADP and MCOLL) were not significantly different among the three groups, and Δt to ADP and collagen(TADP and TCOLL) were not either. But maximum platelet aggregability and Δt to epinephrine(MEPIN and TEPIN) were significantly different among the three groups, and the OC group showed the lowest value (p<0.01). Maxtimum platelet aggregability and Δt during the menstrual cycle were not significantly different in the Pre group. Any other significant differences in the maximum platelet aggregability and Δt were found between oral contraception phase and washing out phase(menstruation) in the OC group. In results, maximum platelet aggregability and aggregation time to ADP and collagen seemed not to be affected by endogenous and exogenous estrogen, even though MEPIN and TEPIN showed significantly low in the OC group among the three groups.

Keywords

References

  1. Annual Report on the Cause of Death Statistics National Statistical Office
  2. N Eng J Med v.330 Hormonal treatment of postmenopausal women Belchetz PE
  3. Clin Chem v.34 no.8B The pathogenesis of atherosclerosis McGill HC
  4. N Eng J Med v.330 The emerging concept of vascular remodeling Gibbons GH;Dzau VJ
  5. Hurst's Heart(9th Ed) Thrombogenesis and antithrombic therapy Verstraete M;Fuster V;Alexander RW;Schlant RC;Fuster V
  6. Circulation v.92 Coronary plaque disruption Falk E;Shah PK;Fuster V
  7. Annals of Medicine v.21 Physiological Functions of Platelets Holmsen H
  8. Am J Clin Pathol v.85 Critical evaluation of platelet aggregation in whole human blood Riess H;Braun G;Brehm G;Hiller E
  9. Thrombosis and Haemostasis v.54 no.3 Platelet aggregation in whole blood: The role of thromboxane A₂and adenosine diphosphate Carter AJ;Heptinstall S
  10. N Eng J Med v.305 Oral contraceptives and cardiovascular disease(1st of 2 parts) Stadel BV
  11. Am J Obstet Gynecol v.163 Clinical aspects of the relationship between oral contraceptives and abnormalities of the hemostatic system: Relation to the development of cardiovascular disease Cecily CK
  12. Am J Obstet Gynecol v.142 Oral contraceptives, clotting factors, and thrombosis Meade YW
  13. J Reprod Med v.28 Hemostatic system changes induced by 50㎍ and 30㎍ estrogen / progestogen oral contraceptives. Modification of estrogen effects by levonorgestrel Sabra A;Bonnar J
  14. Br Med J v.289 Oral contraceptives and stroke: Finding in a large prospective study Vessey MP
  15. J Int Med v.229 Long-term diet modification and platelet activity Beswick AD;Fehily AM;Sharp DS;Renaud S;Giddings
  16. Atherosclerosis v.88 Effects of dietary fish oil supplementation on platelet aggregability and platelet membrane fluidity in normolipemic subjects with and without high plasma Lp(a) concentrations Malle E;Sattler W;Prenner E;Leis HJ;Hermetter A;Gries A;Kostner GM
  17. Lancet v.532 Treatment of atherosclerosis and thrombosis with aspirin Wood L
  18. Atheroscler Res v.7 The variability of human platelet aggregation Harrison MJG;Emmons PR;Mitchell JRA
  19. Rev Prat Nov 1 v.39 no.25 Influence of diet and life habits on platelet function Pechavanne M
  20. Physiology and Pharmacology The Platelets Longenecker GL
  21. Human Physiology(3rd revised) Jung YT
  22. Recommended dietary allowances for Korean(6th revision) The Korean Nutrition Society
  23. Type A behavior and your heart Friedman M;Rosenman R
  24. Diet and Health Methodological considerations in evaluating the evidence Burris JE
  25. R.D.A. Food composition table(5th revision) Rural Nutrition Institute
  26. Platelet function laboratory evaluation and clinical application Specialized laboratory procedures Triplett DA;Harms CS;Newhouse P;Clark C
  27. N Engl J Med v.320 Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenecity Steinberg D;Parthasarathy S
  28. Am J Physiol v.243 Obesity in Osborne-Mendel and S4B / P1 rats: Effects of sucrose solution, castration and treatment with estradiol or insulin Schemmel RA;Teague RJ;Brau GA
  29. Korean J Nutrition v.22 no.2 Long-term effect of ovarectomy on body composition Lee SS;Park JHY
  30. J Korean Med Assoc v.33 no.1 Patterns of circulating gonadotropins(FSH and LH) and steroid hormones(estradiol and progesterone) during the normal menstruation cycles Yoo JO;Yu HK
  31. J Korean Obs & Gyn v.28 no.11 Hormonal changes of LH, FSH, estradiol and progesterone concentrations during menstrual cycles of premenopausal women Yu HK;Rhyu KJ
  32. European J Clin Invest v.20 Platelet aggregability in humans: Contrasting in vivo and in vitro findings during sympatho-adrenal activation and relationship to serum lipids Larsson PT;Hjemdahl P
  33. Agents Actions Suppl v.37 Increase in endogenous fibrinolysis and platelet activity during exercise in young volunteers Beisiegel B;Treese N;Hafner G;Meyer J;Darius H
  34. Thromb Res Oct 1 v.48 no.1 Oral contraceptive steroid induced platelet coagulant hyperactivity: Dissociation of in vivo and in vitro effects Huch KM;Elam MB;Chesney CM
  35. Br Med J v.2 Thromboembolic disease and the steroidal content of oral contraceptives: A report to the committee on safety of drugs Inman WHW;Vessey MP;Westerholm B;Engelund A
  36. Indian J Physiol Pharmacol v.26 no.3 Enhanced platelet aggregation by oral contraceptives: Effect of PG synthetase inhibitors Sudhir S;Cupta LC;Singh J;Garg KN
  37. For use in the evaluation of platelet aggregation BIO / DATA Corp
  38. Nature v.211 Secondary clumping effect in human citrated platelet rich plasma produced by adenosine diphosphate and adrenalin MacMillan DC
  39. Ann Rev Med v.17 Platelet stickiness O'Brien JR
  40. J Hypertens v.7 The hypertension-coronary heart disease dilemma: The catecholamine-blood platelet connection Kjeldsen SE;Neubig RR;Weder AB;Zweifler AJ
  41. Eur J Clin Invest v.20 Platelet aggregability in humans: Contrasting in vivo and in vitro findings during sympatho-adrenal activation and relationship to serum lipids Larsson PT;Hjemdahl P;Olsson G;Angelin B;Hornstra G
  42. Circulation v.66 Plasma catecholamines, platelet aggregation and associated thromboxane formation after physical exercise, smoking or norepinephrine infusion Siess W;Lorenz R;Roth P;Weber PC
  43. Clin Sci v.70 Desensitization of platelet α₂-adrenoceptors after short-term infusions of adrenoceptor agonist in man Jones CR;Giembeyz M;Hamilton CA;Rodger IW;Whyte K;Deighton N;Elliott HL;Reid JL
  44. Prog Cardiovasc Dis v.30 Platelet activation by plasma lipoproteins Aviram M;Brooks JG
  45. Am J Obstet Gynecol v.163 no.1 pt 2 Role of plasma lipoproteins in the pathogenesis of atherosclerotic disease, with special reference to sex hormone effects Tikkanen MJ
  46. Lancet 29 v.343 no.8892 Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal woman Sack MN;Rader DJ;Cannon RO 3rd.
  47. Clin Invest v.71 no.5 Ovarian sex steroids and atherosclerosis Riedel M;Rafflenbeul W;Lichtlen P
  48. Am J Obstet Gynecol v.141 Low-dose oral contraceptive usage and coagulation Notelovitz M;Kitchens CS;Coone L;McKenzie L;Carter R
  49. Am J Epidemiol v.133 Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease Gerstman BB;Piper JM;Tomita DK;Ferguson WJ;Stadel BV;Lundin FE
  50. Am J Obstet Gynecol v.157 Coagulation effects of oral contraception Bonnar J
  51. Adv Contracept v.9 no.3 Evaluation of risk of thrombosis during use of low-dose ethyl estradiol-desogestrel oral contraceptive Massafra C;Butin P;Cavion MA;Minuto SM;Colombini G